Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CurveBeam Career Opportunity: Bringing Critical Thinking as a Regulatory Affairs Associate

On this Jobcast episode CurveBeam Connect, we sat down with Pennsylvania-based Ryan Conlon who is looking for a self-motivated, detail-oriented candidate for the position of Regulatory Affairs Associate. “The most important trait is someone with a little bit of creativity,” Conlon said. “This role is going to require the associate to read and interpret…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from CurveBeam AI on MarketScale.

Share

On this Jobcast episode CurveBeam Connect, we sat down with Pennsylvania-based Ryan Conlon who is looking for a self-motivated, detail-oriented candidate for the position of Regulatory Affairs Associate.

“The most important trait is someone with a little bit of creativity,” Conlon said. “This role is going to require the associate to read and interpret the regulations or standards, and then use your critical thinking to determine how we’re going to be in compliance with these regulations in a fashion that is minimally impactful to our product performance, company goals, and our timelines without ever compromising product or patient safety.”

CurveBeam was founded in 2009 by a group of individuals with a proven track record in the advanced and compact 3D imaging device domain. They’re an energetic company that is innovating and leading the way in orthopedic 3D imaging on a worldwide scale.

Conlon shared insight into the company’s culture, and answered our signature question — If CurveBeam was a band, what band would it be — with a timely reference to one of many hip-hop kings, Travis Scott.

Job basics:

  • Location: Hatfield, Pennsylvania
  • Days of the week: Monday – Friday
  • Travel involved: Minimal, if any
  • Educational requirement: Bachelor’s of Science in Engineering, Science, Regulatory, or a related discipline

If you’re looking for a place where you can work hard and better yourself in an energetic environment, check out Curvebeam job openings, podcasts, and education at CurveBeam.com.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

CurveBeam AI

Part of this channel

CurveBeam AI

AI-powered 3D bone analysis for orthopedic surgical planning.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512